Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
PvP Biologics
company
About
PvP Biologics is developing an oral enzyme for the treatment of celiac disease.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $35M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Nov 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
PvP Biologics is developing an oral enzyme for the treatment of celiac disease. Our mission is to develop a highly-effective therapeutic product to reduce the burden of living with this disease. Towards this end, we are advancing a product candidate designed to break down the immuno-reactive parts of gluten in the stomach and thereby avoid the painful symptoms and damage done in the small intestine from accidental gluten ingestion.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35M
PvP Biologics has raised a total of
$35M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2017 | Series Unknown | $35M | 1 |
Takeda
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
PvP Biologics is funded by 1 investors.
Takeda
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Takeda
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
